scPharmaceuticals Inc. (SCPH)

scPharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.54	75.66	46.81	71.06	74.27	71.82
Short-Term Investments	0.35	1.02	30.36	48.55	1.03	33.28
Cash & Short-Term Investments	57.9	76.68	77.17	119.61	75.3	105.1
Cash Growth	-1.84%	-0.64%	-35.48%	58.85%	-28.35%	44.71%
Accounts Receivable	13.85	11.72	4.49	-	-	-
Receivables	13.85	11.72	4.49	-	-	-
Inventory	14.14	13.9	8.84	1.23	-	-
Prepaid Expenses	3.46	3.55	2.44	2.28	2.79	2.61
Restricted Cash	-	-	-	0.18	0.18	-
Other Current Assets	-	-	-	-	-	0.12
Total Current Assets	89.35	105.85	92.94	123.31	78.28	107.83
Property, Plant & Equipment	1.29	1.33	1.46	0.62	0.48	0.91
Other Long-Term Assets	0.32	0.34	0.08	0.27	0.28	0.31
Total Assets	90.96	107.52	94.48	124.2	79.04	109.05
Accounts Payable	4.99	3.88	4	1.52	0.54	1.67
Accrued Expenses	9.84	9.73	8.75	5.29	3.99	4.75
Current Portion of Long-Term Debt	-	-	-	-	9.81	2.41
Current Portion of Leases	0.25	0.24	0.18	0.57	0.48	0.46
Current Income Taxes Payable	0.07	-	-	-	0.01	0.04
Other Current Liabilities	1.16	1.02	0.21	0.04	0.03	-
Total Current Liabilities	16.31	14.88	13.13	7.42	14.85	9.32
Long-Term Debt	51.05	51.35	38.81	36.79	7.35	16.86
Long-Term Leases	1.05	1.1	1.28	0.01	-	0.48
Other Long-Term Liabilities	27.68	26.87	4.03	7.55	0.37	0.22
Total Liabilities	96.09	94.2	57.26	51.76	22.57	26.88
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	381.1	379.81	318.56	298.93	246.17	243.83
Retained Earnings	-386.24	-366.49	-281.35	-226.54	-189.7	-161.66
Comprehensive Income & Other	-	-	-0	0.03	-0	0
Total Common Equity	-5.13	13.32	37.22	72.43	56.47	82.17
Shareholders' Equity	-5.13	13.32	37.22	72.43	56.47	82.17
Total Liabilities & Equity	90.96	107.52	94.48	124.2	79.04	109.05
Total Debt	52.36	52.69	40.27	37.37	17.64	20.21
Net Cash (Debt)	5.54	23.98	36.9	82.25	57.67	84.89
Net Cash Growth	-69.52%	-35.01%	-55.13%	42.62%	-32.07%	64.53%
Net Cash Per Share	0.11	0.54	0.96	2.90	2.11	3.46
Filing Date Shares Outstanding	52.79	50.28	36.05	35.77	27.37	27.36
Total Common Shares Outstanding	50.28	50.1	35.97	34.26	27.37	27.33
Working Capital	73.04	90.97	79.8	115.89	63.43	98.51
Book Value Per Share	-0.10	0.27	1.03	2.11	2.06	3.01
Tangible Book Value	-5.13	13.32	37.22	72.43	56.47	82.17
Tangible Book Value Per Share	-0.10	0.27	1.03	2.11	2.06	3.01
Machinery	0.13	0.13	0.11	0.15	0.14	0.13
Leasehold Improvements	0.01	0.01	0.01	0.1	0.1	0.1

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q